EW

Edwards Lifesciences Corporation

86.63 USD
-0.02 (-0.02%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Edwards Lifesciences Corporation stock is up 15.77% since 30 days ago. The next earnings date is Apr 24, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58.33% of the previous 23 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 80% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 20:56 17 Jan, 2025 85.00 CALL 22 315
16 Feb 15:10 16 Feb, 2024 82.50 CALL 100 1656
16 Feb 15:56 21 Jun, 2024 77.50 CALL 22 205
16 Feb 16:20 15 Mar, 2024 90.00 PUT 85 345
16 Feb 17:08 15 Mar, 2024 85.00 PUT 235 916
16 Feb 17:11 15 Mar, 2024 90.00 CALL 347 1144
20 Feb 15:38 21 Jun, 2024 82.50 CALL 97 606
20 Feb 20:22 16 Aug, 2024 77.50 PUT 100 8
21 Feb 16:08 21 Jun, 2024 82.50 CALL 34 560
21 Feb 17:56 21 Jun, 2024 90.00 CALL 64 323

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes its products through a direct sales force and independent distributors.

  • Morgan Stanley
    Wed Feb 7, 15:00
    buy
    confirm
  • RBC Capital
    Wed Feb 7, 12:04
    buy
    confirm
  • Mizuho
    Wed Feb 7, 08:42
    buy
    confirm
  • Stifel
    Wed Feb 7, 04:12
    hold
    confirm
  • Wells Fargo
    Fri Feb 2, 10:46
    buy
    upgrade